The National Task Force for Early Identification of Childhood Neuromuscular Disorders convened in 2009 to address the delay that families frequently experience between symptom onset and diagnosis of neuromuscular disorders. The Task Force aims to increase clinicians’ awareness of peripheral neuromuscular disease as a cause of developmental delay in young children, and to help providers in primary care, rehabilitation medicine, and physical therapy identify the early symptoms of neuromuscular disorders.
The Task Force is funded by a cooperative agreement from the CDC and includes representatives from:
American Academy of Pediatrics
American Academy of Neurology
Association of Academic Physiatrists
Childhood Neurology Society
American Academy of Physician Assistants
National Association of Pediatric Nurse Practitioners
National Association of Community Health Centers
American Physical Therapy Association
American Academy of Physical Medicine and Rehabilitation
American Occupational Therapy Association
American Speech Language Hearing Association
National Society of Genetic Counselors
National Coalition for Health Professional Education in Genetics
Parent Project Muscular Dystrophy
Muscular Dystrophy Association
Families of SMA
The chair of the Task Force is Katherine Mathews and the director of the Task Force is Holly Peay.
If transaminases (AST and ALT) are elevated, check CK. Since AST/ALT can come from muscle or the liver, while CK comes only from muscle, this test will help localize the child's problem and may prevent unnecessary liver tests. MORE CLINICAL PEARLS
This website is partially supported by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.